| ²é¿´: 1856 | »Ø¸´: 2 | |||
kevinszu½ð³æ (ÕýʽдÊÖ)
²©Ê¿
|
[ÇóÖú]
ÃÀ¹úFDAÈÏÖ¤µÄËùÓвÄÁϵÄĿ¼ ÒÑÓÐ1È˲ÎÓë
|
| ÃÀ¹úFDAÈÏÖ¤ÁËÄÄЩҩÎïºÍ²ÄÁÏ£¿Çë´óÉñ¸æËßµ½ÄÄÀï¿ÉÒԲ鵽»òÕßÓÐÏà¹ØµÄĿ¼£¿¹òл |
» ²ÂÄãϲ»¶
ÇóÖú·ëÁ¬·¼¡¢ÕŲÅÁÁµÄ¡¶¾ÛºÏ¹ý³ÌÇ¿»¯¼¼Êõ¡·
ÒѾÓÐ1È˻ظ´
2026¿¼²©
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ296È˻ظ´
Õã½ÖÐÒ½Ò©´óѧÕÅÓÂÃñԺʿ2026Ä격ʿÑо¿ÉúÕÐÉú
ÒѾÓÐ3È˻ظ´
ÁòÃÑÑõ»¯
ÒѾÓÐ2È˻ظ´
26²©Ê¿ÉêÇë-Ò©Îﻯѧ·½Ïò
ÒѾÓÐ32È˻ظ´
ÇóÖúcortellisÊý¾Ý¿â²éѯÕë¶Ô°ÐµãABCC6µÄÒ©ÎïºÍÔÚÑзÖ×Ó
ÒѾÓÐ1È˻ظ´
Õ»۵ȱàÖøµÄ¡¶Åäλ»¯Ñ§£ºÔÀíÓëÓ¦Óá·
ÒѾÓÐ1È˻ظ´
ÇóÖú£¡£¡£¡´óÀоÈÃü£¡£¡£¡
ÒѾÓÐ4È˻ظ´
õ£°·ËõºÏ
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇëÎʹúÍâÒѾÉÏÊÐFDAÈÏÖ¤Ò©Æ·ÔÚ¹úÄÚ×¢²á°´3ÀàÉ걨×ܹ²ÐèÒª¶à³¤Ê±¼äÄÜÄÃÖ¤£¿
ÒѾÓÐ5È˻ظ´
2011ÃÀ¹úFDA¹¤ÒÕÑéÖ¤Ö¸ÄÏ
ÒѾÓÐ89È˻ظ´
ÈçºÎÔÚÃÀ¹úFDAÍøÕ¾ÉϲéÕÒзÖ×ÓʵÌåÒ©Î
ÒѾÓÐ4È˻ظ´
Çë½ÌÈçºÎ²éѯÃÀ¹úʳƷҩÎï¹ÜÀí¾Ö(FDA)ÈÏÖ¤¹ýÄÄЩҩÎ
ÒѾÓÐ5È˻ظ´
¹ØÓÚFDAÒ©Æ·¼ÁÐ͵ÄÎÊÌâ
ÒѾÓÐ8È˻ظ´
FDA·¢²¼µÄ×îÐÂÖ¸µ¼ÔÔò201402£ºÒ©Îï·ÖÎö³ÌÐò¼°·½·¨ÑéÖ¤Ö¸µ¼ÔÔò
ÒѾÓÐ171È˻ظ´
¾¹ýÃÀ¹úFDAÅú×¼µÄÖйúÒ©Æ·»ã×Ü
ÒѾÓÐ25È˻ظ´
¹ØÓÚ²éѯÃÀ¹úFDA
ÒѾÓÐ6È˻ظ´
Ò»¸öÉÏÊжàÄêµÄÒ©ÃÀ¹úÒ©µä¡¢Å·ÖÞÒ©µä£¬FDAÊý¾Ý¿âÀï¶¼ÕÒ²»µ½ÐÅÏ¢
ÒѾÓÐ14È˻ظ´
·½´ïÒ½Ò©(Öйú)ÁÙ´²Ñо¿ÖÐÐĺÍÉúÎï·ÖÎöʵÑéÊҳɹ¦Í¨¹ýÃÀ¹úFDA¼ì²é
ÒѾÓÐ13È˻ظ´
δͨ¹ýFDAÈÏÖ¤µÄÖйúÒ©Æó£¬ÄÜ·ñÏòÃÀ¹úFDAÌá³öANDA(¼òÃ÷ÐÂÒ©ÉêÇë)£¿
ÒѾÓÐ2È˻ظ´
ËÜÁϵÄFDAÈÏÖ¤
ÒѾÓÐ5È˻ظ´
FDA»áÈÏ¿ÉÖйú×öµÄÊý¾ÝÂð
ÒѾÓÐ4È˻ظ´
ÈçºÎ²éѯͨ¹ýFDAÈÏÖ¤µÄʳƷÌí¼Ó¼Á£¿
ÒѾÓÐ8È˻ظ´
ÔõÑù´ÓÃÀ¹úFDAÍøÕ¾ÉϲéÕÒ¼°ÏÂÔØÒ©Æ·ËµÃ÷Ê飿
ÒѾÓÐ11È˻ظ´
¡¾ÇóÖú¡¿Ò©Æ·DMF±àд
ÒѾÓÐ9È˻ظ´
¡¾×ªÌû¡¿ÃÀ¹úFDACGMPÏÖ³¡¼ì²éÖ¸ÄÏ.pdf
ÒѾÓÐ46È˻ظ´
¡¾×ªÌû¡¿º£ÆÕÈð¡°¶À¼ÒFDAÈÏÖ¤¡±µÄ½âÎö
ÒѾÓÐ9È˻ظ´

ÆæÔµÆ®Ñ©
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 34 (СѧÉú)
- ½ð±Ò: 878.6
- É¢½ð: 50
- ºì»¨: 3
- Ìû×Ó: 458
- ÔÚÏß: 92.7Сʱ
- ³æºÅ: 1911461
- ×¢²á: 2012-07-26
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
New Molecular Entity and New Therapeutic Biological Product Approvals for 2015 No. Drug Name Active Ingredient Date FDA-approved use on approval date 10. Cholbam cholic acid 3/17/2015 To treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders Press Release 9. Unituxin dinutuximab 3/10/2015 To treat pediatric patients with high-risk neuroblastoma Press Release 8. Cresemba capsule injection isavuconazonium sulfate 3/6/2015 To treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections Press Release 7. Avycaz ceftazidime-avibactam 2/25/2015 To treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no alternative treatment options. Press Release 6. Farydak panobinostat 2/23/2015 To treat patients with multiple myeloma Press Release 5. Lenvima lenvatinib 2/13/2015 To treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive iodine therapy (radioactive iodine refractory disease). Press Release 4. Ibrance palbociclib 2/3/2015 To treat advanced (metastatic) breast cancer Press Release 3. Natpara parathyroid horomone 1/23/2015 To control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism Press Release 2. Cosentyx secukinumab 1/21/2015 To treat adults with moderate-to-severe plaque psoriasis Press Release 1. Savaysa edoxaban 1/8/2015 To reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem Press Release |

2Â¥2015-04-14 16:34:23
3Â¥2015-04-15 08:41:49













»Ø¸´´ËÂ¥